Acadia Pharmaceuticals Inc (ACAD): Weighted Average Diluted Shares
Figures left out. The filed Weighted Average Diluted Shares for the years ended 2020-12-31, 2021-12-31 are not shown: share count out of scale with net income per share. That usually means the filing tagged the figure in the wrong unit.
169.92M
Year ended 2025-12-31
+1.7%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 169.92M | +2.1% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | 166.36M | +1.6% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | 163.82M | +1.3% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | 161.68M | n/c | 2025-02-27, From 2022-01-01 |
| No annual figure between 2012-12-31 and 2022-12-31. | |||
| 2012-12-31 | 55.12M | +5.6% | 2013-03-12, From 2012-01-01 |
| 2011-12-31 | 52.18M | +34.8% | 2013-03-12, From 2011-01-01 |
| 2010-12-31 | 38.72M | +3.3% | 2013-03-12, From 2010-01-01 |
| 2009-12-31 | 37.48M | n/a | 2012-03-06, From 2009-01-01 |